Vaccine Trial Humans
- All
- News
- Videos
-
New HIV Vaccine Candidate Shows Promise In Early Trials
- Tuesday May 21, 2024
- Science | Edited by Nikhil Pandey
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
- www.ndtv.com
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
- Monday January 15, 2024
- World News | Press Trust of India
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
- www.ndtv.com
-
Early-Stage HIV Vaccine Shows Positive Results In Human Trials: Study
- Friday December 2, 2022
- World News | Edited by Nikhil Pandey
In a phase 1 research, 97% of patients had immune system activity in response to the vaccine.
- www.ndtv.com
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
- Wednesday February 9, 2022
- World News | Agence France-Presse
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
- www.ndtv.com
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
- Friday September 3, 2021
- India News | Press Trust of India
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
- www.ndtv.com
-
4 Covid Vaccine Candidates In Human Trial Stage, Centre Tells Rajya Sabha
- Tuesday July 20, 2021
- India News | Press Trust of India
Four COVID-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday.
- www.ndtv.com
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
- Thursday May 27, 2021
- India News | Reuters
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
- www.ndtv.com
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
- Tuesday April 13, 2021
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
- www.ndtv.com
-
US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial
- Friday January 29, 2021
- World News | Reuters
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
- www.ndtv.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Monday January 11, 2021
- Business | Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
- www.ndtv.com/business
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
- Tuesday December 22, 2020
- India News | Reported by Vishnu Som, Edited by Harish Pullanoor
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
- www.ndtv.com
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
- Friday December 11, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
- www.ndtv.com
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
- Thursday December 10, 2020
- India News | Press Trust of India
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
- www.ndtv.com
-
UAE Says China-Developed Sinopharm Covid Vaccine Has 86% Efficacy
- Wednesday December 9, 2020
- World News | Reuters
An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
- www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
- www.ndtv.com
-
New HIV Vaccine Candidate Shows Promise In Early Trials
- Tuesday May 21, 2024
- Science | Edited by Nikhil Pandey
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
- www.ndtv.com
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
- Monday January 15, 2024
- World News | Press Trust of India
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
- www.ndtv.com
-
Early-Stage HIV Vaccine Shows Positive Results In Human Trials: Study
- Friday December 2, 2022
- World News | Edited by Nikhil Pandey
In a phase 1 research, 97% of patients had immune system activity in response to the vaccine.
- www.ndtv.com
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
- Wednesday February 9, 2022
- World News | Agence France-Presse
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
- www.ndtv.com
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
- Friday September 3, 2021
- India News | Press Trust of India
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
- www.ndtv.com
-
4 Covid Vaccine Candidates In Human Trial Stage, Centre Tells Rajya Sabha
- Tuesday July 20, 2021
- India News | Press Trust of India
Four COVID-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday.
- www.ndtv.com
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
- Thursday May 27, 2021
- India News | Reuters
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
- www.ndtv.com
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
- Tuesday April 13, 2021
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
- www.ndtv.com
-
US COVID-19 Vaccine Hopeful Of Using Gates Foundation Cash To Prepare For Human Trial
- Friday January 29, 2021
- World News | Reuters
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
- www.ndtv.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Monday January 11, 2021
- Business | Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
- www.ndtv.com/business
-
Covaxin Crosses Half-Way Mark In Phase-3 Trials, Says Bharat Biotech
- Tuesday December 22, 2020
- India News | Reported by Vishnu Som, Edited by Harish Pullanoor
India's first and only phase III trial of a COVID-19 vaccine has crossed 13,000 subjects - the half-way mark - and proceeding successfully across multiple sites in India, Bharat Biotech, the maker of the inoculant Covaxin, announced today. The trials in the first and second phases had led to promising results.
- www.ndtv.com
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
- Friday December 11, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
- www.ndtv.com
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
- Thursday December 10, 2020
- India News | Press Trust of India
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
- www.ndtv.com
-
UAE Says China-Developed Sinopharm Covid Vaccine Has 86% Efficacy
- Wednesday December 9, 2020
- World News | Reuters
An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
- www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
- www.ndtv.com